Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline

Rhanderson Cardoso; Leslee J. Shaw; Roger S. Blumenthal; Khurram Nasir; Richard Ferraro; David J. Maron; Michael J. Blaha; Martha Gulati; Deepak L. Bhatt; Ron Blankstein

doi:10.1016/j.ajpc.2022.100365

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline

Rhanderson Cardoso, Leslee J. Shaw, Roger S. Blumenthal, Khurram Nasir, Richard Ferraro, David J. Maron, Michael J. Blaha, Martha Gulati, Deepak L. Bhatt, Ron Blankstein

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Abstract

A core principle of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline is the importance of preventive therapies among patients with nonobstructive or obstructive coronary artery disease (CAD). Accordingly, this editorial provides unique insights that emphasize the role of preventive cardiology throughout the new guideline. For the first time, CAD was defined to also include nonobstructive plaque. This definition was based on the fact that individuals who have nonobstructive plaque are at an increased risk of atherosclerotic events compared with those who do not. Herein, we highlight guideline recommendations related to the diagnosis and management of nonobstructive CAD. We also highlight recommendations which emphasize the importance of preventive therapies. Adoption of these recommendations have the potential to lead to enhanced preventive therapies and improve patient outcomes.

Original language	English (US)
Article number	100365
Journal	American Journal of Preventive Cardiology
Volume	11
DOIs	https://doi.org/10.1016/j.ajpc.2022.100365
State	Published - Sep 2022

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ajpc.2022.100365

Cite this

@article{873f0beceb884d2bbbe2a616d0fe922b,

title = "Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline",

abstract = "A core principle of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline is the importance of preventive therapies among patients with nonobstructive or obstructive coronary artery disease (CAD). Accordingly, this editorial provides unique insights that emphasize the role of preventive cardiology throughout the new guideline. For the first time, CAD was defined to also include nonobstructive plaque. This definition was based on the fact that individuals who have nonobstructive plaque are at an increased risk of atherosclerotic events compared with those who do not. Herein, we highlight guideline recommendations related to the diagnosis and management of nonobstructive CAD. We also highlight recommendations which emphasize the importance of preventive therapies. Adoption of these recommendations have the potential to lead to enhanced preventive therapies and improve patient outcomes.",

author = "Rhanderson Cardoso and Shaw, {Leslee J.} and Blumenthal, {Roger S.} and Khurram Nasir and Richard Ferraro and Maron, {David J.} and Blaha, {Michael J.} and Martha Gulati and Bhatt, {Deepak L.} and Ron Blankstein",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = sep,

doi = "10.1016/j.ajpc.2022.100365",

language = "English (US)",

volume = "11",

journal = "American Journal of Preventive Cardiology",

issn = "2666-6677",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline

AU - Cardoso, Rhanderson

AU - Shaw, Leslee J.

AU - Blumenthal, Roger S.

AU - Nasir, Khurram

AU - Ferraro, Richard

AU - Maron, David J.

AU - Blaha, Michael J.

AU - Gulati, Martha

AU - Bhatt, Deepak L.

AU - Blankstein, Ron

PY - 2022/9

Y1 - 2022/9

N2 - A core principle of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline is the importance of preventive therapies among patients with nonobstructive or obstructive coronary artery disease (CAD). Accordingly, this editorial provides unique insights that emphasize the role of preventive cardiology throughout the new guideline. For the first time, CAD was defined to also include nonobstructive plaque. This definition was based on the fact that individuals who have nonobstructive plaque are at an increased risk of atherosclerotic events compared with those who do not. Herein, we highlight guideline recommendations related to the diagnosis and management of nonobstructive CAD. We also highlight recommendations which emphasize the importance of preventive therapies. Adoption of these recommendations have the potential to lead to enhanced preventive therapies and improve patient outcomes.

AB - A core principle of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline is the importance of preventive therapies among patients with nonobstructive or obstructive coronary artery disease (CAD). Accordingly, this editorial provides unique insights that emphasize the role of preventive cardiology throughout the new guideline. For the first time, CAD was defined to also include nonobstructive plaque. This definition was based on the fact that individuals who have nonobstructive plaque are at an increased risk of atherosclerotic events compared with those who do not. Herein, we highlight guideline recommendations related to the diagnosis and management of nonobstructive CAD. We also highlight recommendations which emphasize the importance of preventive therapies. Adoption of these recommendations have the potential to lead to enhanced preventive therapies and improve patient outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85138637817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138637817&partnerID=8YFLogxK

U2 - 10.1016/j.ajpc.2022.100365

DO - 10.1016/j.ajpc.2022.100365

M3 - Letter

AN - SCOPUS:85138637817

SN - 2666-6677

VL - 11

JO - American Journal of Preventive Cardiology

JF - American Journal of Preventive Cardiology

M1 - 100365

ER -

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this